Cardio Health Station

Carotid Intima Media Thickness as a Cardiovascular Risk Factor | As part of our ongoing commitment to provide the latest advancements in preventative medicine, Cenegenics is now offering an additional, state of the art, screening tool for vascular disease called CIMT. CIMT stands for Carotid Intima Media Thickness and refers to the combined thickness of the inner two layers (intima and media) of the carotid artery, which lies in the neck. The measurement of the thickness of the intima and media layers of the common carotid artery is highly predictive of future events (i.e. heart attack, stroke, sudden cardiac death).

CIMT is a painless, noninvasive test that takes about 10-15 minutes to perform. CIMT uses ultrasound (so there is no radiation) and does not require the patient to disrobe.

CIMT is recommended by both the American Heart Association and the American College of Cardiology. As many as 50-60% of those who die from heart attacks or strokes have no previous signs or symptoms. These patients may have been classified as low or intermediate risk based on traditional risk factors. CIMT is more accurate in predicting disease than any other risk factor alone. CIMT significantly improves the assessment of cardiovascular risk in an individual by directly looking at the blood vessels. CIMT will catch more people with disease who were felt to be normal on stress tests. Stress tests only become positive when a patient generally has 70% or greater blockage of a coronary artery. We certainly want to know if we are at risk long before we have a blood vessel that is more than 70% blocked!

See the Cardio Health System device’s page on our site for more information on the specific method/device we will be using to measure CIMT.

The test will be included in the initial Executive Health Evaluation.


Cenegenics uses the Panasonic Cardio Health Station to measure carotid intima media thickness as a cardiovascular risk factor as part of the CIMT exam.

See the downloadable brochure here.

The Cardio health station is FDA cleared, in-office ultrasound imaging that helps you directly identify atherosclerotic cardiovascular disease (ASCVD) allowing you to make a more informed decision about your patients’ treatment options.

The Physician’s Challenge
Assessment of cardiovascular risk in asymptomatic patients Cardiovascular disease is one of the leading causes of death globally. To assess risk, doctors typically review traditional risk factors, such as total cholesterol, blood pressure, smoking history, age, gender, lipid profile (HDL/LDL levels), and family history. However, these conventional tests can be poor predictors of future atherothrombotic events. Relying on these factors may result in misclassification of risk. In a major study of 136,905 patients hospitalized with coronary artery disease, only 23% had high LDL levels* (above 130 mg/dl) and would be identified by traditional risk factors. Yet in a large outcome study of 10,000 asymptomatic subjects with a 10 year follow-up (mean age = 53), ultrasound identified 98.6% of future atherothrombotic events.**

*Sachdeva et al. AHJ, Vol 157, 111-117, Jan 2009

**Belcaro G, et al. Atherosclerosis 2001; 156: 379-387

The Panasonic Solution: Find a Plaque, Treat It.
We have engineered a product that not only improves your ability to see the underlying disease, but also fits seamlessly into your treatment regimen. Innovative ultrasound imaging technology allows for direct identification of atherosclerotic cardiovascular disease (ASCVD). By combining traditional risk factors with imaging, physicians are able to gather a more comprehensive understanding of their patients’ cardiovascular health.

The CardioHealth Station in the hands of a trained
professional is the perfect in-office tool. Driven by advanced hardware, it automates many of the steps which a sonographer would usually need to understand and perform, making it easy to start using right away and on your own schedule.

Easy to Integrate into Your Practice to Help You Start Making Informed Decisions

Carotid Intima-Media Thickness (CIMT) and Plaque Assessment by Trained Medical Residents: Validation and Preliminary Testing of a Training Protocol.
A recent study published by physicians out of Mayo Clinic and the University of Southern California assessed how easy it was to train medical residents to use ultrasound imaging to identify plaque and measure CIMT. The conclusion was that it was easy to rapidly train medical residents, who had no prior ultrasound training, to identify ASCVD with an accuracy comparable to experts.*

*Aldridge et al., J Am Soc Echocardiogr. Sept 2013. pii:S0894-7317(13)00635-4

Rapid Screening for Subclinical Atherosclerosis by Carotid Ultrasound Examination. The HAPPY (Heart Attack Prevention Program for You) Substudy.
A major study done in India, under the guidance of leading physicians from Mt. Sinai, sought to determine the feasibility of performing ultrasound imaging in a rural young population with few to no risk factors. The results proved that not only was rapid community screening of subclinical atherosclerosis possible, but also useful for identifying the high prevalence of atherosclerotic cardiovascular disease (ASCVD) where traditional risk factors
were not available.*
*Singh, Fuster, Narula et al., Global Heart. Vol. 8, No. 2, 83-89, June 2013

The above articles are not shown as an endorsement of the CardioHealth Station, but rather as a highlight of publically available scientific data, which may be referred to by the medical professional.

Back to Top

CardioHealth Station | Find a Plaque, Treat It.

The CardioHealth Station brings efficiency, innovation, and reliability to your medical practice. As a pioneer in its field, it offers improvements in workflow without disrupting your current routine, allowing you to use it on
your own schedule. The tool you always wished you had is finally here to help you make more informed decisions.

Efficiency

A powerful in-office solution allowing you to image patients and find the results in real-time, on your own schedule. Automation and proper training gives you a powerful tool for plaque detection.*

Reliability

Automation delivered with proprietary technology gives you a reproducible and reliable solution for your practice. Only product in the industry to be FDA cleared for its automated acquisition of IMT measurements of the peripheral vessels.**

Innovation

Provides real-time arterial plaque imaging allowing you to make more informed decisions while also creating a unique way to increase patient adherence to therapy through proper counseling.

*Aldridge et al., J Am Soc Echocardiogr. 2013 Sep 16. pii:S0894-7317(13)00635-4
**Accurate as of March 2011

The Whole Test Can Take Just 5 Minutes…

  1. Enter information and start ultrasound scan.
  2. Assess for plaque and measure IMT through automation.
  3. Generate comprehensive report and recommend next steps.

Instant Results

In most cases, the entire test takes no longer than five minutes allowing you to create a comprehensive cardiovascular risk assessment very quickly. A detailed report is generated based on traditional risk factor scores (FRAMINGHAM, SCORE or PROCAM) and the results of the ultrasound examination (plaque and IMT) are plotted against your choice of a major study, whether it be ARIC, MESA, or CAPS. Developed in close cooperation with key opinion leaders in preventive cardiology and subclinical atherosclerosis imaging, the report is optimized for you and your patients. The combination of schematic and actual ultrasound images to depict wall thickness and arterial plaque may serve as a clever solution to increasing patient adherence to treatment.


Back to Top

Comprehensive Report Generated with Images

CENEGENICS AGE MANAGEMENT

CENEGENICS AGE MANAGEMENT

 

**Metric report also available

Back to Top

Carotid Plaque

CENEGENICS PHOENIX ARIZONA CIMT CHS DEVICE IMAGE Carotid Plaque

Femoral Plaque

CENEGENICS PHOENIX ARIZONA CIMT CHS DEVICE IMAGE Femoral Plaque

Back to Top


New Treatment Guidelines

Is Testing for Atherosclerotic Disease Recommended?

Yes! Detecting early stage Atherosclerosis by finding focal lesions or an abnormal IMT is more highly recommended by national societies than several other well-known tests.

Test USA* Europe**
Plaque/IMT Class IIA Class IIA (Strong)
CAC Class IIA Class IIA (Weak)
LP(a) Class III Class IIA
HEMOGLOBIN A1C Class IIB
RESTING ECG Class IIB
LP-PLA2 Class IIB Class IIB
ARTERIAL STIFFNESS Class III
ENDOTHELIAL FUNCTION Class III

*2010 ACC / AHA Guidelines | **2012 ESC Guidelines

Carotid intima-media thickness measurement is a quantitative measurement of atherosclerosis

What do the Treatment Guidelines Say?

There are two major treatment guidelines to turn to:

  • 2012 ESC Guidelines – Treatment Recommendation
    • In the prevention of non-haemorrhagic stroke, treatment with statins must be started in all patients with established atherosclerotic disease and in patients at high risk for developing cardiovascular disease.
  • 2002 NCEP ATP III
    • “…Persons with clinical forms of non-coronary atherosclerosis should have the same LDL-cholesterol goal (<100 mg/dL) as those for persons with established coronary heart disease and should be managed similarly…”

Back to Top

Key Automatic Features

CENEGENICS AGE MANAGEMENT

(A) Result Of IMT Measurement Calculated from automation based on the radio frequency data received by the ultrasound probe. Measurement accuracy not dependent on image quality and resolution.
(B) Auto Roi Determines depth of carotid and region of interest to vessel far wall automatically.
(C) Auto Trigger Performs a real-time analysis of the movements of carotid wall from change in vessel diameter and automatically detects cardiac enddiastole when IMT is the thickest.
(D) Auto Imt Determines the intima-media thickness through the collection of raw data and is not dependent on the image resolution.
(E) Angle Display Angle is displayed and recorded along with the IMT measurement.
(F) Auto Freeze Freezes automatically (measurement completed) when reliability of IMT measurement reaches high quality, and trigger occurs.

Back to Top

CardioHealth Station Technical Specifications

Display LCD Monitor with touch panel (Size:15 inch)
Weight 13 kg (includes transducer, desk stand, and holder)
Modes Of Operation B Mode / BIMT Mode / CFD / PWD (Realtime / Freeze)
Power 100 V to 240 V
Ultrasound Image View • Direction rotates 90ºC or totation (Vertical/Horizontal)
• Depth 2 cm-5 cm
• Transducer Angle Recording
Transducer • Linear array
• Center frequency (8.9 MHz)
• Cable length (1.5 m)+A1
Operation Environment (Includes Transducer) • Ambient temperature: 10ºC to 35ºC
• Relative humidity: 35% to 80% (no condensation)
Size 406(W)x131(D)x394(H) Excludes stand and holder
Image Paramter Settings Auto Freeze Condition (Difficult / Normal / Easy)
Memory For Imaging • Multi-angle IMT measurement mode
• Plaque search mode (B-mode/CFD/PWD)
• Auto IMT measurement
• Modify trace
Beam Focus Full digital, transmit focus step 1 (single), dynamic receive focusing
Reports • CardioHealth report
• DICOM format export
• Network export capability
• Optional USB printer
Data Storage • Ultrasound images
• Patient information
• Angle information
• Measurement information
• Image parameter setting

Back to Top

Dr. C.B. Daniel Cenegenics AZ Elite Health and Age Management
Send